PFE Pfizer Dashboard

Pfizer applies science and its global resources to bring therapies to people that extend and significantly improve their lives. It strives to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with its responsibility as one of the world's premier innovative biopharmaceutical companies, it collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, it has worked to make a difference for all who rely on it. It routinely posts information that may be important to investors on its website at www.Pfizer.com.

Company profile

Ticker

PFE

Exchange

NYSE

Website

www.pfizer.com

CEO

Albert Bourla

Incorporated

Delaware

Location

New York

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Johnson & Johnson • Merck & Co • Allergan • Abbott Laboratories • Teva- Pharmaceutical Industries • Lilly(Eli) & Co • Bristol-Myers Squibb • Viatris • Warner Chilcott • Abbvie ...

SEC CIK

0000078003

Corporate docs

Articles of Incorporation & Bylaws

PFE stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

Unusual Options Activity Insight: Pfizer

30 Jul 21

On Friday, shares of Pfizer (NYSE:PFE) saw unusual options activity. After the option alert, the stock price moved up to $42.83.

Strong Month; Weak Finish: Stocks, Treasury Yields Under Pressure In Early Friday Trading

30 Jul 21

Whether you’re running for the gold medal in Tokyo or running for honor in the three-legged race at the summer barbecue, it’s no fun to stumble at the finish.

Is Now The Time To Buy Stock In Pfizer, Coinbase Global Or Texas Roadhouse?

30 Jul 21

One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why a stock is moving.

Elon Musk, Jeff Bezos & Richard Branson: Which Market Leaders Will Make Up The Cannabis Industry Space Race?

30 Jul 21

Mizuho Maintains Neutral on Pfizer, Raises Price Target to $43

30 Jul 21

Press releases

Pro users get this 30m faster

Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer?

30 Jul 21

NEW YORK, July 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TEAM, CRSP, QGEN, AAPL, and PFE.

Thinking about trading options or stock in Pfizer, JD.Com, Pinduoduo, Facebook, or American Express?

28 Jul 21

NEW YORK, July 28, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE, JD, PDD, FB, and AXP.

PFIZER REPORTS SECOND-QUARTER 2021 RESULTS

28 Jul 21

Second-Quarter 2021 Revenues of $19.0 Billion, Reflecting 86% Operational Growth; Excluding BNT162b2(1), Revenues Grew 10% Operationally to $11.1 Billion The 10% Operational Growth Excluding BNT162b2(1) in

Thinking about trading options or stock in Skechers USA, Pinterest, American Express, Facebook, or Pfizer?

23 Jul 21

Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.

23 Jul 21

Calendar

13 May 21

30 Jul 21

31 Dec 21

Financial summary

Financial statements Chart PFE financial data

Quarter (USD)	Apr 21	Dec 20	Sep 20	Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Pfizer earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	1.81B	1.81B	1.81B	1.81B	1.81B	1.81B
Cash burn (monthly)	5.33M	32.25M	(positive/no burn)	(positive/no burn)	(positive/no burn)	(positive/no burn)
Cash used (since last report)	20.64M	124.82M	n/a	n/a	n/a	n/a
Cash remaining	1.79B	1.68B	n/a	n/a	n/a	n/a
Runway (months of cash)	335.3	52.2	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Recent insider trades

PFE insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
15 Jul 21	John D Young	Phantom Stock Units SSP Common Stock	Grant	Aquire A	No	No	40.09	11	440.99	52,834
15 Jul 21	Rady A Johnson	Phantom Stock Units SSP Common Stock	Grant	Aquire A	No	No	40.09	4	160.36	6,610
15 Jul 21	Jennifer B. Damico	Phantom Stock Units SSP Common Stock	Grant	Aquire A	No	No	40.09	31	1.24K	14,672
15 Jul 21	Albert Bourla	Phantom Stock Units SSP Common Stock	Grant	Aquire A	No	No	40.09	12	481.08	88,599
13 Jul 21	Albert Bourla	Phantom Stock Units SSP Common Stock	Grant	Aquire A	No	No	39.65	48	1.9K	88,595

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2021

PFE institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

64.2% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2584	2603	-0.7%
Opened positions	159	304	-47.7%
Closed positions	178	157	+13.4%
Increased positions	1171	1226	-4.5%
Reduced positions	1055	886	+19.1%

13F shares	Current	Prev Q	Change
Total value	130.1B	136.16B	-4.5%
Total shares	3.59B	3.7B	-2.8%
Total puts	54.02M	56.14M	-3.8%
Total calls	44.1M	63.75M	-30.8%
Total put/call ratio	1.2	0.9	+39.1%

Largest owners	Shares	Value	Change
Vanguard	450.91M	$16.34B	+0.7%
BLK Blackrock	405.73M	$14.7B	+2.2%
STT State Street	274.89M	$9.96B	-1.7%
Wellington Management	249.78M	$9.05B	+1.3%
Capital World Investors	230.09M	$8.34B	-13.7%
Geode Capital Management	94.15M	$3.4B	+4.1%
BAC Bank Of America	67.85M	$2.46B	-0.9%
NTRS Northern Trust	65.05M	$2.36B	-2.5%
BK Bank Of New York Mellon	61.94M	$2.24B	-4.3%
State Farm Mutual Automobile Insurance	56.54M	$2.05B	0.0%

Largest transactions	Shares	Bought/sold	Change
Norges Bank	0	-60.3M	EXIT
Capital World Investors	230.09M	-36.56M	-13.7%
AMP Ameriprise Financial	17.94M	+9.45M	+111.3%
BLK Blackrock	405.73M	+8.76M	+2.2%
Charles Schwab Investment Management	50.57M	+8.57M	+20.4%
TROW T. Rowe Price	23.27M	-8.28M	-26.3%
Canada Pension Plan Investment Board	13.77M	+7.65M	+125.2%
BEN Franklin Resources	26.55M	+7.53M	+39.6%
MS Morgan Stanley	46.31M	-7.3M	-13.6%
Two Sigma Investments	7.08M	+7.08M	NEW

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Akorn • TherapeuticsMD • GT Biopharma • Church & Dwight • Teligent • Celldex Therapeutics • Acura Pharmaceuticals • Immucell • Heron Therapeutics • Brickell Biotech

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	7th grade Avg

New words: acetate, administered, adolescent, Amplyx, ANDA, Aug, Aurobindo, back, Baltimore, Biden, BLA, BOD, booster, castration, compromised, constraining, contraceptive, corridor, Cosmetic, Council, Cutaquig, debilitating, Dec, decided, dedicated, Dohme, Duchenne, dynamic, dystrophy, Energy, essentially, estradiol, EUA, evenly, Facebook, Feb, Fee, feedback, fit, fordadistrogene, Fosmanogepix, fungal, geopolitical, healthy, immunoglobulin, implied, institution, instrument, interpretation, intravenously, invoiced, ISDA, Israel, IVIg, Jan, justifying, Keytruda, LinkedIn, LOE, managerial, Mar, Maryland, master, Mayor, merit, movaparvovec, MTM, muscular, Myovant, norethindrone, Nov, occurrence, Oct, Octagam, PGS, Presidential, principle, proportionately, Relugolix, remittance, restated, retail, revocation, rolling, run, sasanlimab, sensitive, Sept, Sharp, sovereign, speak, sponsored, Stewardship, Surveillance, transparency, twelve, Twitter, unasserted, undergoing, undertaken, unduly, user, Uterine, vigorously, war, warrant, website, YouTube

Removed: AA, AbbVie, Abrilada, abrocitinib, ACA, accelerate, acceptable, accommodate, accounted, accretion, acid, ACIP, acquire, acquiring, adalimumab, adult, Advair, advantage, adversely, advocacy, affirmed, affordability, affordable, aggressively, Aid, Ajanta, allocated, alopecia, Amgen, AML, amplify, Amsparity, Anacor, analytical, analyze, announcement, antibody, Anticoagulant, antirheumatic, Apotex, approve, approximate, areata, Argentina, arrangement, assessed, assign, assigned, assuming, assurance, asterisk, atopic, atorvastatin, atrial, attendant, attention, automate, automation, avelumab, axial, axitinib, Bamboo, battle, BCG, began, benchmark, beta, biologic, Biotechnology, blend, Bosulif, bosutinib, BRAF, Brazil, breast, Breckenridge, bridge, broad, budget, building, burden, buy, calcium, calculate, California, calling, capacity, capsule, carcinoma, cardiomyopathy, Carolina, CDI, CDK, cell, center, cGMP, charitable, checkpoint, children, Citrate, clarifying, clarity, cleaning, clinically, closely, cloud, CML, collaborate, colorectal, column, combat, commencing, commensurate, commercialization, commercialize, commercially, commingled, commitment, committing, commonly, community, comparative, comparing, comparison, compel, compliance, comply, composed, computing, confidence, confirmed, confluence, conform, conjugate, construct, consummation, contact, contracted, contracting, controlled, conversion, converted, convertible, creating, CreditWatch, crisaborole, Crohn, curing, customary, cytarabine, Daurismo, de, debarment, decade, decline, deconsolidated, decreased, deem, defaulting, deficiency, Del, delivering, demerger, denial, depend, derive, designate, designated, designation, detected, determination, diagnosed, differentiated, difficile, dilated, directed, disability, disadvantaged, disciplined, distancing, distinct, diverse, dividing, doctor, document, domestic, domestically, doubtful, Dr, dual, easily, EBITDA, education, efficient, elaparvovec, element, eligible, eliminating, emerge, employment, enable, enabler, ending, endpoint, enhance, enrollment, ensuring, entity, equally, equate, equipment, Esteve, Eucrisa, evolving, exacerbation, exclusionary, executing, exhibit, existed, expectation, expertise, exploring, expression, extend, facilitating, fairly, family, FASB, Fast, favor, feared, feasible, fibrillation, fidanacogene, fiduciary, field, fighting, finalized, firm, firmly, fluctuate, footnote, footprint, force, formal, Fosun, free, FTC, fulfilling, fund, gene, generate, German, glasdegib, Glossary, governance, governing, GPD, grow, guarantee, half, heading, hemophilia, hepatocellular, hereditary, holding, honoring, hormone, hospitalization, Huahai, Humira, hyperinflationary, hypothetical, IBT, Immunology, import, importation, impose, inadequate, inadequately, inappropriate, incidence, inclusive, incorporate, independently, ineffective, infected, Inflammation, Inflectra, infusion, Inhub, initially, initiative, Injection, injunction, innovation, innovator, inspect, inspection, intention, interaction, interbank, intolerant, intubation, investing, Ireland, issuance, issuer, Italy, job, join, juvenile, Kerydin, kinase, lactamase, Lamin, launched, leadership, led, legislatively, leukemia, lorlatinib, lose, lost, lowered, lung, Lyme, lymphocytic, lymphoma, MabThera, maker, manager, managing, mandated, materialize, maturing, maximize, McPherson, mCSPC, MDL, medically, Medivation, methotrexate, microscopic, midpoint, mild, minimize, mixed, moderating, modification, modified, molecule, monoclonal, Moody, Morbidity, mortality, moved, mRNA, multiplying, mutation, myriad, natural, NDMA, necessarily, Neulasta, nmCRPC, notch, noted, noting, Notwithstanding, novo, OA, obligor, obtained, offered, offering, Official, oncology, opening, Opiate, opinion, opioid, opportunity, optimize, option, organize, organized, Organizing, original, outbreak, overhead, Oversight, owed, ownership, page, par, parity, PARP, pathway, paying, PCAOB, pegfilgrastim, penetration, Pensa, percent, performed, periodically, perpetual, pharmacy, physician, pilot, pivotal, plaque, pneumonia, pneumoniae, point, population, portray, positioned, post, potent, power, powerful, precipitate, preferred, preliminarily, preliminary, Premarin, prepare, prescribe, prescribing, presently, prevalent, Prevenar, preventable, preventing, Prinston, proceed, produce, profit, progressed, progression, prolonged, promotional, prophylactic, proportion, proprietary, protein, publication, purport, pursuing, put, qualified, qualify, quantifying, RA, rapid, rapidly, rare, rated, rating, rationalization, RCC, reach, reallocating, recall, receive, recognizing, recommend, recommendation, reconciliation, reconciling, recoup, recruitment, recur, redecide, redeemed, redemption, referred, refine, refocused, refund, refused, regulate, regulator, reliable, reliant, remained, Remicade, remotely, reorganized, repay, repayment, repeal, replenish, reportable, repurchase, repurchased, requirement, resolved, resource, responded, responding, responsibility, resume, reversal, Reverse, reviewed, revision, rheumatoid, ritlecitinib, Rituxan, Roche, room, satisfaction, scale, science, scope, screening, secondary, seizure, Select, selective, sharing, show, shown, side, Sildenafil, Similarly, simpler, simplify, SIP, smaller, social, software, Solco, somatrogon, Spain, specialty, specifically, speed, spend, spread, stage, stand, standalone, stayed, stemming, streamlining, strict, strongest, structured, submit, substitute, sued, suggest, Sulperazon, sum, Summarized, Sun, superior, supportable, supported, suppurativa, surface, surgical, survival, suspension, sustainable, symptomatic, system, systemic, Tadalafil, tailored, tavaborole, taxation, TCJA, TEC, territorial, test, testing, Therachon, therapy, therefrom, tiered, timeframe, today, tolerated, Track, transform, transitioning, transmission, transthyretin, travel, treating, tyrosine, UC, ultimate, unaudited, unchanged, underserved, underwritten, undue, unemployment, unmet, unpaid, unprecedented, unqualified, unreasonable, unrecognized, unsecured, unsuccessful, untreated, upgraded, uptake, urothelial, USP, utilized, utilizing, vacated, vaccinate, vaccination, VAI, Valneva, valuation, varenicline, variation, VBP, Venezuela, venture, vi, viable, vii, viii, ViiV, violate, visit, Viwit, volatile, voluntary, voted, Vyndamax, Vyndaqel, wake, warfarin, warning, Weekly, widespread, withdraw, withdrawal, Wixela, workforce, WRDM, Zavicefta, Zhejiang, Zithromax

From filing 10-Q 2021 Q1